We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.64B
AUM Growth
+$133M
Cap. Flow
-$13.9M
Cap. Flow %
-0.53%
Top 10 Hldgs %
24.71%
Holding
1,609
New
116
Increased
589
Reduced
837
Closed
60

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11M
2
PEP icon
PepsiCo
PEP
+$10.1M
3
META icon
Meta Platforms (Facebook)
META
+$4.84M
4
ABBV icon
AbbVie
ABBV
+$4.59M
5
GILD icon
Gilead Sciences
GILD
+$3.42M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$31.2M
2
NVDA icon
NVIDIA
NVDA
+$21.4M
3
TXN icon
Texas Instruments
TXN
+$14.9M
4
QCOM icon
Qualcomm
QCOM
+$13.7M
5
AVGO icon
Broadcom
AVGO
+$11.4M

Sector Composition

Rank Sector Weight
1 Healthcare 22.1%
2 Technology 22.1%
3 Communication Services 12.31%
4 Consumer Discretionary 11.73%
5 Financials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
151
Nike
NKE
$61.9B
$3.03M 0.11%
35,728
+770
+2% +$61.8K
EGHT icon
152
8x8 Inc
EGHT
$247M
$3.03M 0.11%
142,415
-2,066
-1% -$45K
NTES icon
153
NetEase
NTES
$76.5B
$3.01M 0.11%
66,035
-7,555
-10% -$347K
XLNX
154
DELISTED
Xilinx Inc
XLNX
$3M 0.11%
37,380
-34,536
-48% -$2.53M
BBD icon
155
Banco Bradesco
BBD
$38.1B
$2.99M 0.11%
673,820
+39,912
+6% +$184K
BDX icon
156
Becton Dickinson
BDX
$43.1B
$2.98M 0.11%
11,706
+2,940
+34% +$724K
LGND icon
157
Ligand Pharmaceuticals
LGND
$6.02B
$2.97M 0.11%
17,346
-50
-0.3% -$7.54K
OXY icon
158
Occidental Petroleum
OXY
$57B
$2.96M 0.11%
35,984
-800
-2% -$64.7K
CRL icon
159
Charles River Laboratories
CRL
$10.9B
$2.94M 0.11%
21,812
+684
+3% +$84.4K
FISV
160
Fiserv Inc
FISV
$27.2B
$2.89M 0.11%
35,103
+1,779
+5% +$140K
ELV icon
161
Elevance Health
ELV
$81.9B
$2.89M 0.11%
10,550
+2,805
+36% +$728K
PRAH
162
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.87M 0.11%
26,068
+3,794
+17% +$395K
PBR.A icon
163
Petrobras Class A
PBR.A
$107B
$2.87M 0.11%
274,135
+104,704
+62% +$1.02M
NEM icon
164
Newmont
NEM
$99.5B
$2.81M 0.11%
93,149
-351
-0.4% -$11.9K
SGEN
165
DELISTED
Seagen Inc. Common Stock
SGEN
$2.81M 0.11%
36,381
+3,434
+10% +$253K
VTRS icon
166
Viatris
VTRS
$20.1B
$2.79M 0.11%
76,246
+24,108
+46% +$905K
D icon
167
Dominion Energy
D
$62.5B
$2.76M 0.1%
39,210
+4,528
+13% +$321K
HON icon
168
Honeywell
HON
$77B
$2.76M 0.1%
18,336
+619
+3% +$87.7K
MCHP icon
169
Microchip Technology
MCHP
$42.8B
$2.75M 0.1%
69,654
-64,166
-48% -$2.83M
AET
170
DELISTED
Aetna Inc
AET
$2.73M 0.1%
13,448
+3,427
+34% +$670K
TCOM icon
171
Trip.com Group
TCOM
$27.5B
$2.73M 0.1%
73,310
-11,645
-14% -$473K
PM icon
172
Philip Morris
PM
$301B
$2.71M 0.1%
33,244
+925
+3% +$75.9K
HDB icon
173
HDFC Bank
HDB
$119B
$2.71M 0.1%
115,012
+2,140
+2% +$54.6K
BLUE
174
DELISTED
bluebird bio
BLUE
$2.7M 0.1%
1,429
+226
+19% +$467K
ALNY icon
175
Alnylam Pharmaceuticals
ALNY
$36.3B
$2.68M 0.1%
30,620
+4,671
+18% +$470K
5 6
7
8 9

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Profund Advisors held 1,609 positions worth $2.64B, up 5.3% from $2.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Profund Advisors's Q3 2018 filing shows 116 new, 589 increased, 837 reduced and 60 closed positions. Its largest new stake was Sarepta Therapeutics: 21,343 shares worth $3.45M. The largest sale was Intel, an estimated $31.2M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.

  • Profund Advisors's largest Q3 2018 buy was Sarepta Therapeutics: 21,343 shares worth $3.45M.
  • Profund Advisors added most to Amazon in Q3 2018, an estimated $11M increase.
  • Profund Advisors's biggest Q3 2018 reduction was Intel, cutting an estimated $31.2M.
  • Profund Advisors fully exited Cavium, Inc. in Q3 2018, selling an estimated $1.28M.
  • Profund Advisors's ten largest holdings make up 25% of its $2.64B portfolio in Q3 2018.
  • Profund Advisors opened 116 new positions and closed 60 in Q3 2018.
  • Profund Advisors's portfolio value rose 5.3% quarter-over-quarter to $2.64B.

Based on Profund Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.